JVDI Advertisement
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Veterinary Diagnostic Investigation Vol. 20 Issue 6, 789-791
Copyright © 2008 by the American Association of Veterinary Laboratory Diagnosticians
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laborde, J. M.
Right arrow Articles by Galosi, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laborde, J. M.
Right arrow Articles by Galosi, C. M.

Brief Research Reports

Evaluation of an indirect enzyme-linked immunosorbent assay for routine screening of Theiler's murine encephalomyelitis virus antibodies in mice colonies

Juan M. Laborde, Cecilia Carbone, Santiago G. Corva and Cecilia M. Galosi1

Correspondence: 1Corresponding Author: Cecilia M. Galosi, Department of Virology, Faculty of Veterinary Sciences, National University of La Plata, 60 and 118, PO Box 296, 1900 La Plata, Buenos Aires, Argentina. cmgalosi{at}fcv.unlp.edu.ar, cmgalosi{at}yahoo.com


    Abstract
 TOP
 Abstract
 Sources and manufacturers
 References
 
The current study demonstrates the ability of an indirect enzyme-linked immunosorbent assay (iELISA) to detect antibodies against Theiler's murine encephalomyelitis virus in mice colonies. The antigen was produced from infected baby hamster kidney (BHK)-21 cells and treated with 1% Nonidet P40 in saline buffer. Control antigen was prepared following the same procedure using uninfected BHK-21 cells. The optimal antigen and serum dilutions were established. The reaction was revealed using an anti-mouse–horseradish peroxidase conjugate and 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid). Optimized iELISA was validated by detection of antibodies in known positive and negative serum samples before testing the samples of unknown status. Performance of the iELISA was compared with the indirect fluorescent antibody test, and the cutoff value was determined by receiver operating curve. Indirect ELISA showed 100% sensitivity, 99.38% specificity, and 97.78% predictive positive value. The antigen used is easy to produce, and no special equipment is required. The iELISA developed is simple and provides a rapid and less costly tool for diagnosis and research.

Key Words: Diagnosis • enzyme-linked immunosorbent assay • Theiler's murine encephalomyelitis virus

Theiler's murine encephalomyelitis virus (TMEV), an enteric pathogen of mice that belongs to the Cardiovirus genus in the family Picornaviridae, is a common cause of asymptomatic enteric infections in mice housed in nonbarrier animal colonies.1 In addition, TMEV spreads to the central nervous system (CNS) to cause poliomyelitis (flaccid paralysis) and, more rarely, encephalitis.11 Theiler's murine encephalomyelitis virus can be divided into 2 groups on the basis of biological activities and the disease produced after intracerebral inoculation of mice. The first group consists of 2 highly virulent strains (GDVII and FA), which produce an acute fatal encephalitis in adult mice.

Members of the Theiler's original group are less virulent and cause CNS disease in the form of poliomyelitis followed by a chronic inflammatory demyelinating disease, which is due to viral persistence. Worldwide spreading is indicated.2,8 This demyelinating disease has immune parameters and histopathology similar to those of chronic progressive multiple sclerosis (MS) and thus is extensively studied as an infectious model for MS.4,6,10 The 2 most commonly used serological tests for diagnosis of TMEV-infected mice are the indirect fluorescent antibody test (IFAT) and the enzyme-linked immunosorbent assay (ELISA). The IFAT is the test of choice for detection of infection because it is rapid, simple to perform, and can be used for a small sample size. The ELISA has now been recognized as an excellent alternative to the conventional IFAT, one with high sensitivity and specificity. Other recognized advantages of the ELISA are the simple and automated procedures.12 Some ELISA procedures employing partially purified virus or synthetic peptides have been used for the detection of TMEV, but they require special technology for antigen (Ag) production.5,7 In the current report, a simple indirect ELISA (iELISA) performed with a solubilized Ag was developed to analyze a large sample size and to use it for screening mice colonies.

For Ag preparation, the GDVII strain of TMEV was propagated on baby hamster kidney (BHK)-21 cells grown in Eagle minimum essential medium supplemented with 10% fetal calf serum, 0.3 mg/ml of glutamine, 200 IU/ml of penicillin, 0.5 mg/ml of streptomycin, and 10% tryptose phosphate broth. The infected cultures were harvested when 90% of the cells exhibited cytopathic effect, clarified by centrifugation, and were washed twice with phosphate-buffered saline (PBS). One percent of Nonidet P40a in Tris (0.01 mol) and ethylenediamine tetra-acetic acid (EDTA; 0.001 mol, pH 7.4) saline buffer was used to lyse and solubilize the pellet of TMEV-infected cells at 1:100 of original volume. The lysate was centrifuged at 8,000 x g for 30 min, and the supernatant was used as a source of Ag for the iELISA. Control Ag was prepared following the same procedure, but with uninfected BHK-21 cells. The optimal Ag dilution was established by titrating an Ag dilution series against a varying dilution of a reference positive serum. The optimal serum dilution was chosen based on the lowest dilution of the positive sera tested with control Ag, which showed optical density (OD) values of less or equal to those presented by negative reference serum tested with viral Ag at the same concentration. Plate coating was carried out using 0.1 ml of the predetermined Ag dilution (1:1,000) in carbonate/bicarbonate buffer (0.05 mol, pH 9.6) in all wells of flat-bottomed, polystyrene microtiter plates (protein concentration, 0.5 µg/well). The plates were incubated at 4°C overnight in a humid chamber and then blocked with 100 µl of blocking buffer (0.05% Tween-20 in PBS [PBST] containing 5% skim milk powder). After 1 hr of incubation at 37°C, the wells were washed 5 times (for 5 min each wash) with PBST. Sera diluted 1:40 in blocking buffer were added to a 50-µl volume and incubated for 1 hr at 37°C. After repeating the 5 washes for 5 min with PBST, the anti-mouse–horseradish peroxidase conjugate diluted in blocking buffer (1:1,000) was added (50 µl/well) and incubated for 1 hr at 37°C. The plates were washed as previously described, and substrate solution containing 0.1 mol of citric acid, 0.2 mol of sodium phosphate, 0.003% H2O2, and 0.3 mg/ml of 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)a was added in each well in 0.1-ml aliquots. The color reaction developed at 20 min and was read on a microplate spectrophotometer.b To minimize day-to-day variation, all serum samples were tested in duplicate on 2 different days, and the results were expressed as the average of 4 OD values. Optimized iELISA was validated by detection of antibody (Ab) in known positive (experimentally infected mice: n = 20) and negative (reference specific pathogen–free: n = 20) serum samples (based on IFAT status) before testing the samples of unknown status (n = 208) provided by 10 conventional facilities.

The performance of the developed iELISA was compared with that of IFAT. The IFAT was developed with infected cell suspensions dropped on spot slides, fixed, and stored at –20°C until used. Test sera were overlaid onto the spots, incubated for 30 min at 37°C, and washed off with PBS. The anti-mouse antiserum (fluorescein isothiocyanate–conjugated anti–immunoglobulin G)c was added onto the spots, incubated for 30 min at 37°C, and positive fluorescence were observed.

The performance of iELISA in terms of relative sensitivity and specificity was compared to that of the IFAT, and the cutoff value was determined by receiver operating curve. A 2-sided contingency table was constructed with the obtained results. Indirect ELISA showed 100% sensitivity, 99.38% specificity, and 97.78% predictive positive value. All samples with OD values >0.115 were considered positive (Table 1). The 21.15% of the sera analyzed were found to be positive.


View this table:
[in this window]
[in a new window]

 
Table 1 Comparison of results obtained from 208 mice sera of conventional facilities analyzed by indirect fluorescent antibody test (IFAT) and indirect enzyme-linked immunosorbent assay (iELISA).*

 
Routine screening is needed in all mice colonies used for research, and the IFAT was used for several years with satisfactory results. However, when it is necessary to analyze a large number of samples, the IFAT is more laborious, and subjective results can be present. The present study demonstrates the ability of an iELISA to detect TMEV Ab in mice colonies. The iELISA used in the current study was sensitive, specific, precise, rapid, and easily automated and could represent a good alternative assay for detection of TMEV Ab in routine serodiagnosis of mice colonies. A recent study concerning MS refers to the use of an antigen for ELISA prepared with partially purified virus Theiler.9 This could also be considered a good alternative, but this method requires a higher centrifugation speed to concentrate virus particles. However, the Ag production method developed in the present study and previously used for another veterinary assay3 is simple and easily performed. It did not require special equipment and provides a rapid and less costly tool for diagnosis of and research on TMEV. An important finding that emerged from the results of the present study was that the Argentine mice colonies analyzed were found to be seropositive. These data have 2 implications: 1) the virus is circulating in conventional facilities; and 2) the virus could interfere with research that involves the CNS. In addition, data indicates that a complete prevalence study of TMEV Ab in mice colonies of Argentina should be performed.


    Acknowledgments
 
C. M. Galosi is a member of the Scientific Research Commission, Buenos Aires, Argentina. This study was supported by grants from the Department for Science and Technology at the National University of La Plata and the Scientific Research Commission (CIC), Buenos Aires, Argentina. The authors would like to acknowledge the professional assistance of Prof. Marcelo Pecoraro (Department of Virology, Faculty of Veterinary Sciences, National University of La Plata).


    Sources and manufacturers
 TOP
 Abstract
 Sources and manufacturers
 References
 
From the Departments of Laboratory Animals (Laborde, Carbone), Epidemiology (Corva), and Virology (Galosi), Faculty of Veterinary Sciences, National University of La Plata, Buenos Aires, Argentina; and the Scientific Research Commission, Buenos Aires, Argentina (Galosi). Back

a. Sigma-Aldrich, St. Louis, MO. Back

b. Titertek Multiskan Plus, EFLAB, Helsinki, Finland. Back

c. Zymed Laboratories Inc., South San Francisco, CA. Back


    References
 TOP
 Abstract
 Sources and manufacturers
 References
 

  1. Brownstein D., Bhatt P., Ardito R., et al. 1989 Duration, patterns of transmission of Theiler's mouse encephalomyelitis virus infection. Lab Anim Sci 39 299 301.[Medline]
  2. Calenoff M.A., Faaberg K.S., Lipton H.L. 1990 Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. Proc Natl Acad Sci U S A 87 978 982.[Abstract/Free Full Text]
  3. Echeverría M.G., Nosetto E.O., Etcheverrigaray M.E. 2000 Evaluation of a blocking ELISA using a urease conjugated for the detection of antibodies to pseudorabies virus. J Vet Diagn Invest 12 266 268.[Abstract/Free Full Text]
  4. Grant R.A., Filman D.J., Fujinami R.S., et al. 1992 Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A 89 2061 2065.[Abstract/Free Full Text]
  5. Inoue A., Choe Y., Kim B.S. 1994 Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J Virol 68 3324 3333.[Abstract/Free Full Text]
  6. Kang B.S., Lyman M.A., Kim B.S. 2002 Differences in avidity and epitope recognition of CD8+ T cells infiltrating the central nervous systems of SJL/L mice infected with BeAn and DA strains of Theiler's murine encephalomyelitis virus. J Virol 76 11780 11784.[Abstract/Free Full Text]
  7. Lipton H.L., Kim B.S., Yahikozawah, Nadler C.F. 2001 Serological evidence that Mus musculus is the natural host of Theiler's murine encephalomyelitis. Virus Res 76 79 86.[Medline]
  8. Miyata H., Sato H. 1990 Theiler's murine encephalomyelitis virus: characterization of newly isolated viruses from Japanese mouse colonies. Jikken Dobutsu 39 539 548.[Medline]
  9. Pachner A.R., Libin L., Narayan K. 2007 Intrathecal antibody production in an animal model of multiple sclerosis. J Neuroimmunol 185 57 63.[Medline]
  10. Roussarie J.P., Ruffie C., Brathic M. 2007 The role of myelin in Theiler's virus persistence in the central nervous system. PLoS Pathog 3 (2) e23 pp.[Medline]
  11. Theiler M. 1937 Spontaneous encephalomyelitis of mice, a new virus disease. J Exp Med 163 620 631.
  12. Waggie K., Kagiyama N., Allen A., Nomura T. 1994 Manual of microbiologic monitoring of laboratory animals, 2nd ed. (NIH publication 94-2498) Bethesda, MD U.S. Department of Health and Human Services, National Institutes of Health.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laborde, J. M.
Right arrow Articles by Galosi, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laborde, J. M.
Right arrow Articles by Galosi, C. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS